PT98026A - Processo para a preparacao de um derivado de aspartil-fenilalanina util como inibidor de agregacao de plaquetas - Google Patents

Processo para a preparacao de um derivado de aspartil-fenilalanina util como inibidor de agregacao de plaquetas

Info

Publication number
PT98026A
PT98026A PT98026A PT9802691A PT98026A PT 98026 A PT98026 A PT 98026A PT 98026 A PT98026 A PT 98026A PT 9802691 A PT9802691 A PT 9802691A PT 98026 A PT98026 A PT 98026A
Authority
PT
Portugal
Prior art keywords
agglutinator
platelets
aspartic
preparation
phenylalanine derivative
Prior art date
Application number
PT98026A
Other languages
English (en)
Other versions
PT98026B (pt
Inventor
Foe Siong Tjoeng
Steven Paul Adams
Larry Philip Feigen
Original Assignee
Monsanto Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monsanto Co filed Critical Monsanto Co
Publication of PT98026A publication Critical patent/PT98026A/pt
Publication of PT98026B publication Critical patent/PT98026B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/14Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/021Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)n-C(=0)-, n being 5 or 6; for n > 6, classification in C07K5/06 - C07K5/10, according to the moiety having normal peptide bonds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06104Dipeptides with the first amino acid being acidic
    • C07K5/06113Asp- or Asn-amino acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Plant Substances (AREA)
PT98026A 1990-06-20 1991-06-19 Processo para a preparacao de um derivado de aspartil-fenilalanina util como inibidor de agregacao de plaquetas PT98026B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/540,953 US5053393A (en) 1988-07-20 1990-06-20 Novel platelet-aggregation inhibitor

Publications (2)

Publication Number Publication Date
PT98026A true PT98026A (pt) 1992-04-30
PT98026B PT98026B (pt) 1998-11-30

Family

ID=24157584

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98026A PT98026B (pt) 1990-06-20 1991-06-19 Processo para a preparacao de um derivado de aspartil-fenilalanina util como inibidor de agregacao de plaquetas

Country Status (17)

Country Link
US (1) US5053393A (pt)
EP (1) EP0462960B1 (pt)
JP (1) JPH0651719B2 (pt)
KR (1) KR940000753B1 (pt)
AT (1) ATE123293T1 (pt)
AU (1) AU631070B2 (pt)
CA (1) CA2044978C (pt)
DE (1) DE69110091T2 (pt)
DK (1) DK0462960T3 (pt)
ES (1) ES2075415T3 (pt)
FI (1) FI106380B (pt)
IE (1) IE72519B1 (pt)
IL (1) IL98557A (pt)
NO (1) NO301373B1 (pt)
NZ (1) NZ238611A (pt)
PT (1) PT98026B (pt)
ZA (1) ZA914728B (pt)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5332726A (en) * 1989-09-29 1994-07-26 Rhone-Poulenc Rorer Pharmaceuticals Inc. Antithrombotic peptides and pseudopeptides
TW201303B (pt) * 1990-07-05 1993-03-01 Hoffmann La Roche
US5260277A (en) * 1990-09-10 1993-11-09 Tanabe Seiyaku Co., Ltd. Guanidinyl and related cell adhesion modulation compounds
NZ239846A (en) * 1990-09-27 1994-11-25 Merck & Co Inc Sulphonamide derivatives and pharmaceutical compositions thereof
MX9201416A (es) * 1991-03-28 1992-10-01 Rhone Poulenc Rorer Int Peptidos y pseudopeptidos antitromboticos.
DE4126277A1 (de) * 1991-08-08 1993-02-11 Cassella Ag Hydantoinderivate
US5239113A (en) * 1991-10-15 1993-08-24 Monsanto Company Substituted β-amino acid derivatives useful as platelet aggregation inhibitors and intermediates thereof
US5254573A (en) * 1991-10-15 1993-10-19 Monsanto Company Substituted heterocyclic derivatives useful as platelet aggregation inhibitors
US5625093A (en) * 1991-10-15 1997-04-29 G. D. Searle & Co. Substituted β-amino acid derivatives useful as platelet aggregation inhibitors
WO1993008823A1 (en) * 1991-11-06 1993-05-13 Tanabe Seiyaku Co., Ltd. Guanidinyl and related cell adhesion modulation compounds
US5258398A (en) * 1991-12-16 1993-11-02 Rhone-Poulenc Rorer Pharmaceuticals Inc. Antithrombotic diaminoalkanoic acid derivatives
TW223629B (pt) * 1992-03-06 1994-05-11 Hoffmann La Roche
US5338725A (en) * 1992-06-30 1994-08-16 The Research Foundation Of The State University Of New York Anti-aggregatory agents for platelets
US6380163B1 (en) * 1992-12-22 2002-04-30 Baxter International Inc. Peritoneal dialysis solutions with polypeptides
DE4302485A1 (de) * 1993-01-29 1994-08-04 Merck Patent Gmbh Piperazinderivate
EP0682529B2 (en) * 1993-02-09 2005-12-28 Biogen Idec MA, Inc. Antibody for the treatment of insulin dependent diabetes
ATE181735T1 (de) * 1993-05-01 1999-07-15 Merck Patent Gmbh Substituierte 1-phenyl-oxazolidin-2-on derivate, deren herstellung und deren verwendung als adhäsionsrezeptor-antagonisten
TW394760B (en) * 1993-09-07 2000-06-21 Hoffmann La Roche Novel Carboxamides, process for their preparation and pharmaceutical composition containing the same
DE4332384A1 (de) * 1993-09-23 1995-03-30 Merck Patent Gmbh Adhäsionsrezeptor-Antagonisten III
DE4405378A1 (de) * 1994-02-19 1995-08-24 Merck Patent Gmbh Adhäsionsrezeptor-Antagonisten
DE4429461A1 (de) * 1994-08-19 1996-02-22 Merck Patent Gmbh Adhäsionsrezeptor-Antagonisten
ES2123889T3 (es) * 1994-11-02 1999-01-16 Merck Patent Gmbh Antagonistas de receptores de adhesion.
DE4439846A1 (de) * 1994-11-08 1996-05-09 Merck Patent Gmbh Adhäsionsrezeptor-Antagonisten
DE19504954A1 (de) * 1995-02-15 1996-08-22 Merck Patent Gmbh Adhäsionsrezeptor-Antagonisten
DE19516483A1 (de) 1995-05-05 1996-11-07 Merck Patent Gmbh Adhäsionsrezeptor-Antagonisten
US7018627B1 (en) 1995-06-07 2006-03-28 Icos Corporation Macrophage derived chemokine (MDC), MDC analogs, MDC inhibitor substances, and uses thereof
US5891418A (en) * 1995-06-07 1999-04-06 Rhomed Incorporated Peptide-metal ion pharmaceutical constructs and applications
US5654334A (en) * 1995-06-23 1997-08-05 Oklahoma Medical Research Foundation Analgesic use of N-L-α-aspartyl-L-phenylalanine 1-methyl ester
US5872122A (en) * 1997-10-16 1999-02-16 Monsanto Company Pyrimidinylamidino β-amino acid derivatives useful as inhibitors of platelet aggregation

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2215948B1 (pt) * 1973-02-01 1976-05-14 Centre Etd Ind Pharma
US4127580A (en) * 1975-02-07 1978-11-28 Parcor Process for the preparation of thieno-pyridine derivatives
US4589881A (en) * 1982-08-04 1986-05-20 La Jolla Cancer Research Foundation Polypeptide
US4661111A (en) * 1982-08-04 1987-04-28 La Jolla Cancer Research Foundation Polypeptide
US4517686A (en) * 1982-08-04 1985-05-21 La Jolla Cancer Research Foundation Polypeptide
US4614517A (en) * 1982-08-04 1986-09-30 La Jolla Cancer Research Foundation Tetrapeptide
US4578079A (en) * 1982-08-04 1986-03-25 La Jolla Cancer Research Foundation Tetrapeptide
US4683291A (en) * 1985-10-28 1987-07-28 Scripps Clinic And Research Foundation Platelet binding inhibitors
US4857508A (en) * 1987-12-03 1989-08-15 Monsanto Company Novel platelet-aggregation inhibitor peptide derivatives
US4992463A (en) * 1988-07-20 1991-02-12 Monsanto Company Thienyl peptide mimetic compounds which are useful in inhibiting platelet aggregation
US4879313A (en) * 1988-07-20 1989-11-07 Mosanto Company Novel platelet-aggregation inhibitors
US5169836A (en) * 1988-11-10 1992-12-08 Trustees Of The University Of Penna. Inhibitors of platelet binding
CA2008116C (en) * 1989-02-23 2001-11-20 Thomas Weller Glycine derivatives

Also Published As

Publication number Publication date
NZ238611A (en) 1992-09-25
CA2044978C (en) 2001-06-12
AU631070B2 (en) 1992-11-12
IE72519B1 (en) 1997-04-23
JPH04230299A (ja) 1992-08-19
DE69110091D1 (de) 1995-07-06
ATE123293T1 (de) 1995-06-15
FI913006A (fi) 1991-12-21
FI106380B (fi) 2001-01-31
IL98557A0 (en) 1992-07-15
EP0462960A1 (en) 1991-12-27
DK0462960T3 (da) 1995-10-02
KR920000785A (ko) 1992-01-29
FI913006A0 (fi) 1991-06-19
EP0462960B1 (en) 1995-05-31
IE912100A1 (en) 1992-01-01
AU7912191A (en) 1992-01-02
JPH0651719B2 (ja) 1994-07-06
ZA914728B (en) 1993-02-24
US5053393A (en) 1991-10-01
NO301373B1 (no) 1997-10-20
CA2044978A1 (en) 1991-12-21
PT98026B (pt) 1998-11-30
IL98557A (en) 1996-01-31
KR940000753B1 (ko) 1994-01-29
NO912396L (no) 1991-12-23
DE69110091T2 (de) 1996-02-08
NO912396D0 (no) 1991-06-19
ES2075415T3 (es) 1995-10-01

Similar Documents

Publication Publication Date Title
PT98026A (pt) Processo para a preparacao de um derivado de aspartil-fenilalanina util como inibidor de agregacao de plaquetas
PT99261A (pt) Processo para a preparacao de herbicidas a base de aril-haloalquilpirazoles substituidos
BR9005452A (pt) Processo para preparacao de compostos e os ditos compostos
ES2138956T3 (es) Imidazoquinoxalinonas, sus analogos aza y procedimiento para su preparacion.
PT91602A (pt) Processo para a preparacao de compostos espiro com accao antibacteriana e de composicoes farmaceuticas que os contem
PT90622A (pt) Processo para a preparacao de derivados acilo de 2-aminobenzotiazol, uteis como agentes anti-neoplasticos
PT82097B (pt) Processo para a preparacao de derivados de labdano e de composicoes farmaceuticas que os contem
ES2022115B3 (es) Procedimiento de produccion de polimeros que contienen amida alcoxilados/modificados cationicamente
PT92768A (pt) Processo para a preparacao de analogos amida das prostaglandinas heterociclicas substituidas com 7-oxabicicloheptilos
DE69033069D1 (de) Prostaglandinanaloge
PT83418B (pt) Processo para a preparacao de derivados de analogos de mitomicina c
PL286043A1 (en) Method for manufacturing new proteins
PT92503A (pt) Processo para a preparacao de novos derivados peptidicos com accao anti-coagulante
PT89667B (pt) Processo para a modificacao de um crivo molecular
ATE130009T1 (de) Antitumor-aminosäuren und peptid-derivate von 1,4-bis((aminoalkyl und hydroxyaminoalkyl)amino>5,8- dihydroxyanthraquinonen.
PT90212A (pt) Processo aperfeicoado para a preparacao de derivados de 3-fenoloxi-3-fenil-propanaminas
PT90019A (pt) Processo para a preparacao e purificacao de factor de choque termico humano
PT90273A (pt) Processo para a preparacao de derivados de aminoacidos
ES537558A0 (es) Un procedimiento para la preparacion del isomero r (dextrogiro)
FI901277A0 (fi) 2,5,6,7-tetranor-4,8-inter-m-fenylen pg1z-derivativ.
DE69116251D1 (de) Verfahren zur Herstellung von 6-(substituiertes Aminopropionyl)-Derivaten von Forskolin
PT91941A (pt) Processo para a preparacao de n,n'-di-(trimetoxi-benzoil)piperazinas substituidas por 2-carbonilo
NO903927D0 (no) N-azabicyklo(3.3.0)oktan-amider av aromatiske syrer.
BR8805500A (pt) Processo para preparacao de isotiazolonas substituidas com halogenio
PT92668A (pt) Processo para a preparacao de derivados de azabiciclo-heptano

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19911206

FG3A Patent granted, date of granting

Effective date: 19980807